RSS

Horizon 2020

First patient has been implanted with a novel drug delivery system, developed by Renishaw, for a new clinical study investigating it as a delivery method for cerebral dopamine neurotrophic factor (CDNF) as a treatment for Parkinson’s disease. more

Technology

Scottish biotechnology company, TC BioPharm (TCB), has been selected to receive a €4 million grant from the European Union’s (EU’s) research and innovation programme, Horizon 2020. more

News

Scientific technology company Renishaw is being supported by the Horizon 2020 programme for its trials of a new drug delivery system aiming to help treat Parkinson’s disease. more

News

A £4m trial will establish whether routinely treating stoke patients with paracetamol and antibiotics could save up to 25,000 lives each year. more

News